2025-10-14 - Analysis Report
Okay, here's an analysis of Salesforce Inc. (CRM) based on the provided data, presented in a clear and concise manner with an emphasis on key insights.

## Salesforce Inc. (CRM) Analysis

**0. Executive Summary:**

Salesforce (CRM) shows mixed signals.  While recent news and analyst sentiment are positive, the stock has significantly underperformed the S&P 500.  Recent earnings and revenue are positive, but the long-term expected return is significantly negative. Investors should proceed with caution, considering the stock's high volatility.

**1. Performance vs. S&P 500 (VOO):**

*   **Accumulated Rate of Return:**
    *   CRM: -8.34%
    *   VOO: 96.68%
*   **Divergence:**
    *   Current Divergence: -110.0
    *   Relative Divergence: 0.8
    *   Interpretation: CRM has significantly underperformed the S&P 500. The relative divergence indicates that the current underperformance is near the lower end of its historical range.

*   **Company Overview:** Salesforce is a global leader in cloud-based software, providing customer relationship management (CRM) services.

*   **Alpha/Beta Analysis:**

    | Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
    |------------|--------|--------|--------|--------|--------|
    | 2015-2017  | 39.0%  | 70.6%  | 10.0%  | -0.0   | 97.3   |
    | 2016-2018  | 34.0%  | 73.5%  | 19.0%  | 0.1    | 130.4  |
    | 2017-2019  | 22.0%  | 73.5%  | 0.0%   | 0.4    | 154.8  |
    | 2018-2020  | 14.0%  | 73.5%  | -10.0% | 0.4    | 211.8  |
    | 2019-2021  | 37.0%  | 71.9%  | -10.0% | 0.7    | 241.9  |
    | 2020-2022  | -78.0% | 74.7%  | -78.0% | 0.4    | 126.2  |
    | 2021-2023  | -47.0% | 76.6%  | -49.0% | -0.6   | 250.5  |
    | 2022-2024  | -42.0% | 76.6%  | -63.0% | -0.4   | 318.3  |
    | 2023-2025  | 3.0%   | 76.6%  | -58.0% | -2.0   | 236.8  |

    *   **Analysis:** The table shows a history of varying performance. Alpha has been significantly negative in recent periods, indicating underperformance relative to the market. Beta has fluctuated, indicating changing correlation with the market (S&P 500). High MDD(maximum drawdown) indicates high risk.

**2. Recent Stock Price Movements:**

*   **Current Price:** 248.75
*   **Last Market Data:**
    *   Price: 248.75
    *   Previous Close: 241.68
    *   Change: 2.93 (Significant upswing)
*   **Moving Averages:**
    *   5-day: 242.45
    *   20-day: 242.29
    *   60-day: 247.68
*   **Analysis:** The price is above all moving averages, suggesting a short-term upward trend. The recent price change of 2.93 indicates a strong positive movement.

**3. Market Risk Indicators:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommendation)
*   **RSI:** 54.04 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.34 (Indicates potential upward momentum, but not extremely strong)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Divergence Change:** +0.2 (Short-term Increase)
*   **Expected Return:** -4589.8%
    *   **Analysis:** The MRI suggests a medium level of risk. The Hybrid Signal is bullish, but the extremely negative expected return is a major concern. The recent increase in relative divergence suggests a short-term upward trend.

**4. Recent News & Significant Events:**

*   **Positive Developments:**  The tech sector is gaining, Telnyx is integrating with Salesforce, and Docusign is recognized in Salesforce's Partner Innovation Awards.
*   **Mixed Signals:** One article questions whether PLTR's recent surge makes it a buy or a wait.
*   **Overall:**  The news is generally positive, with specific integrations and sector-wide gains potentially benefiting Salesforce.

**4-2. Analyst Opinions:**

*   **Analyst Consensus:** Buy (~1.6 on a 1-5 scale)
*   **Opinions:** 51
*   **Target Price (avg/high/low):** 334.38 / 430.00 / 221.00
*   **Recent Rating Changes:**  No changes provided.
*   **Analysis:** Analysts are generally bullish on CRM with a buy consensus and a significant average target price above the current price.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-09-04 | 1.97 | 10.24 B$  |
| 2025-05-29 | 1.61 | 9.83 B$   |
| 2024-12-04 | 1.6  | 9.44 B$   |
| 2024-08-29 | 1.48 | 9.32 B$   |
| 2025-09-04 | 1.48 | 9.32 B$   |
*   **Analysis:** Both EPS and Revenue have been generally increasing, indicating positive financial performance.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-07-31   | $10.24B    | 78.10%        |
| 2025-04-30   | $9.83B     | 76.96%        |
| 2025-01-31   | $9.99B     | 77.81%        |
| 2024-10-31   | $9.44B     | 77.71%        |
| 2024-07-31   | $9.32B     | 76.85%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-07-31   | $61.33B    | 3.08%  |
| 2025-04-30   | $60.67B    | 2.54%  |
| 2025-01-31   | $61.17B    | 2.79%  |
| 2024-10-31   | $58.52B    | 2.61%  |
| 2024-07-31   | $57.63B    | 2.48%  |

*   **Analysis:**  Revenue and profit margins are high, indicating strong operational efficiency. Equity is growing, and ROE is relatively stable.

**7. Overall Analysis:**

*   **Strengths:**
    *   Strong revenue and profit margins.
    *   Positive analyst sentiment and target price.
    *   Positive recent news and sector trends.
    *   Recent price increase and short-term upward momentum.
*   **Weaknesses:**
    *   Significant underperformance compared to the S&P 500.
    *   Extremely negative long-term expected return.
    *   High MDD(maximum drawdown)
*   **Concerns:** The discrepancy between the positive financial performance and analyst sentiment, versus the significant underperformance and extremely negative expected return, is a major red flag.
*   **Recommendation:**  Due to the conflicting signals, a cautious approach is warranted. Further investigation is needed to understand the drivers behind the underperformance and the extremely negative expected return. Investors should consider their risk tolerance and investment horizon before making any decisions regarding CRM.
